임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

40건 표시

3상모집 중· Non-small Cell Lung Cancer
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
리드: 머크(MSD) · 협력: 모더나
상세 →NCT07513376
2상모집 중· Lyme Disease
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)
리드: 모더나
상세 →NCT07561294
3상모집 중· Influenza
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
리드: 모더나
상세 →NCT07496450
1상모집 중· Epstein-Barr Virus
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age
리드: 모더나
상세 →NCT07478952
1상모집 중단 (진행 중)· HIV Infections
Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall Good Health in South Africa.
협력: 모더나
상세 →NCT06694753
2상모집 중· Squamous Non-small Cell Lung Cancer
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
리드: 머크(MSD) · 협력: 모더나
상세 →NCT07221474
4상모집 중단 (진행 중)· COVID-19
Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19
협력: 모더나
상세 →NCT07279766
4상모집 중단 (진행 중)· SARS-CoV-2
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
리드: 모더나
상세 →NCT07266558
1/2상모집 중· Relapsed or Refractory Multiple Myeloma
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
리드: 모더나
상세 →NCT07116616
1상모집 중· Cutaneous Melanoma
ACTengine® IMA203 Combined With mRNA-4203
협력: 모더나
상세 →NCT06946225
2상모집 중· Multiple Sclerosis
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
리드: 모더나
상세 →NCT06735248
1상모집 중단 (진행 중)· Advanced Solid Tumors
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
리드: 모더나
상세 →NCT06880549
2상모집 중· Urinary Bladder Neoplasms
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
리드: 머크(MSD) · 협력: 모더나
상세 →NCT06833073
1상모집 중단 (진행 중)· Healthy Participants
A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants
리드: 모더나
상세 →NCT06655870
3상모집 중· Carcinoma, Non-Small-Cell Lung
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
리드: 머크(MSD) · 협력: 모더나
상세 →NCT06623422
3상모집 중단 (진행 중)· Acute Gastroenteritis
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
리드: 모더나
상세 →NCT06592794
4상모집 중· SARS-CoV-2
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
리드: 모더나
상세 →NCT06585241
2상모집 중단 (진행 중)· Renal Cell Carcinoma
A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).
리드: 머크(MSD) · 협력: 모더나
상세 →NCT06307431
1/2상모집 중단 (진행 중)· Bladder Cancer
A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)
리드: 머크(MSD) · 협력: 모더나
상세 →NCT06305767
3상모집 중· Non-small Cell Lung Cancer
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
리드: 머크(MSD) · 협력: 모더나
상세 →NCT06077760
3상모집 중단 (진행 중)· Respiratory Syncytial Virus
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults
리드: 모더나
상세 →NCT06067230
1/2상모집 중단 (진행 중)· Norovirus Acute Gastroenteritis
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
리드: 모더나
상세 →NCT05992935
단계 미표기모집 중· Cytomegalovirus Infections
Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study
협력: 모더나
상세 →NCT06522880
3상모집 중단 (진행 중)· Melanoma
A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)
리드: 머크(MSD) · 협력: 모더나
상세 →NCT05933577
단계 미표기모집 중· Propionic Acidemia
A Retrospective Study to Characterize Participants With Propionic Acidemia
리드: 모더나
상세 →NCT05769621
2상모집 중단 (진행 중)· Cytomegalovirus Infection
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.
리드: 모더나
상세 →NCT05683457
1상모집 중단 (진행 중)· Epstein-Barr Virus Infection
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants
리드: 모더나
상세 →NCT05831111
단계 미표기모집 중단 (진행 중)· SARS-CoV-2
Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGE
리드: 모더나
상세 →NCT06333704
1상모집 중단 (진행 중)· Respiratory Syncytial Virus
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months
리드: 모더나
상세 →NCT05743881
1/2상모집 중단 (진행 중)· Herpes Zoster
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age
리드: 모더나
상세 →NCT05701800
1/2상모집 중· Advanced Solid Tumors
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
리드: 모더나
상세 →NCT05533697
1/2상모집 중단 (진행 중)· Glycogen Storage Disease
A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)
리드: 모더나
상세 →NCT05095727
단계 미표기모집 중단 (진행 중)· Myocarditis
A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)
리드: 모더나
상세 →NCT06189053
1/2상모집 중· Methylmalonic Acidemia
An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
리드: 모더나
상세 →NCT05295433
1/2상모집 중단 (진행 중)· Epstein-Barr Virus Infection
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults
리드: 모더나
상세 →NCT05164094
1/2상모집 중· Propionic Acidemia
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
리드: 모더나
상세 →NCT05130437
1/2상모집 중· Propionic Acidemia
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
리드: 모더나
상세 →NCT04159103
2상모집 중단 (진행 중)· Melanoma
An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)
리드: 모더나 · 협력: 머크(MSD)
상세 →NCT03897881
1상모집 중단 (진행 중)· Solid Tumors
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors
리드: 모더나 · 협력: 머크(MSD)
상세 →NCT03313778
초기 1상모집 중단 (진행 중)· Carcinoma, Intraductal, Noninfiltrating
Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)
협력: 머크(MSD), 모더나
상세 →NCT02872025

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.